| Tuesday, December 3, 2024 |
|---|
| Stay Ahead of the Curve: The Plan to Manage Increased Cancer Patient Volumes | 10:00 AM - 10:45 AM | | Erik Manthei, MHA, FACHE, Administrative Director, Oncology, Henry Mayo & Keck Medicine Joint Venture, Keck Medicine of USC
Kerri Celaya, MA, FACHE, Director, Cancer Services, Penn Medicine Princeton Health
Debra Wilson, MSN, RN, OCN, Vice President, Operations, Lee Health Cancer Institute, Lee Health
Robin Famiglietti, PhD, MBA, FACHE, Associate Vice President and Associate Dean, Duke Cancer Institute |
| Oncology in the Next 5 Years: Tackling Big Issues and Building Great Teams | 10:45 AM - 11:30 AM | | John Montville, Executive Director, Oncology Service Line, Lourdes Hospital, Mercy Health
Wendy Mbugua, MSN, RN, NEA-BC, FACHE, MSN, RN, NEA-BC, FACHE, Vice President, Oncology Service Line, Sharp HealthCare
David Rivadeneira, MD, MBA, FACS, FASCRS, Director, Northwell Health Cancer Institute at Huntington, Northwell Health
Tim Pluard, MD, Medical Director, Saint Luke's Cancer Institute and Koontz Center for Advanced Breast Cancer |
| Top Oncology Innovations and Research to Watch | 11:30 AM - 12:15 PM | | Shalom Kalnicki, MD, Associate Director, Clinical Affairs, Montefiore Einstein Comprehensive Cancer Center, Montefiore Medicine
Bhavesh Shah, RPh, BCOP, Chief Pharmacy Officer, Specialty and Hematology Oncology Pharmacy, Boston Medical Center
Richard Berri, MD, Chief, Surgical Oncology and Medical Director, Ascension Michigan Oncology
Shane Dormady, MD, Director, Medical Oncology, El Camino Health Cancer Center |